tiprankstipranks
Arvinas Holding Company (ARVN)
NASDAQ:ARVN
US Market

Arvinas Holding Company (ARVN) Similar Stocks

Compare
956 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Arvinas Holding Company
$7.59
$521.98M
-81.21%
12 Buy
5 Hold
0 Sell
Moderate Buy
Blueprint Medicines
$88.72
$5.67B
-6.47%
14 Buy
4 Hold
0 Sell
Strong Buy
CytomX Therapeutics
$0.63
$50.32M
1.60
-70.79%
3 Buy
1 Hold
0 Sell
Strong Buy
Nurix Therapeutics
$12.15
$922.02M
-16.67%
11 Buy
2 Hold
0 Sell
Strong Buy
Kymera Therapeutics
$29.62
$1.92B
-26.32%
12 Buy
2 Hold
0 Sell
Strong Buy
Biohaven Ltd.
$27.65
$2.82B
-46.89%
10 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ARVN
Arvinas Holding Company
7.59
-32.81
-81.21%
BPMC
Blueprint Medicines
88.72
-7.70
-7.99%
CTMX
CytomX Therapeutics
0.63
-1.52
-70.70%
NRIX
Nurix Therapeutics
12.15
-2.43
-16.67%
KYMR
Kymera Therapeutics
29.62
-9.80
-24.86%
BHVN
Biohaven Ltd.
27.65
-24.41
-46.89%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis